Sustained Nano Systems has a total of 40 patents globally, out of which 15 have been granted. Of these 40 patents, more than 75% patents are active. The United States of America is where Sustained Nano Systems has filed the maximum number of patents. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Sustained Nano Systems.
Sustained Nano Systems was founded in 2014. Sustained Nano Systems is a biotech company. They provide a flagship technology that allows for both short-term and long-term micro dosing to target the cell for various therapeutic applications.
Do read about some of the most popular patents of Sustained Nano Systems which have been covered by us in this article and also you can find Sustained Nano Systems patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Sustained Nano Systems patent portfolio.
How many patents does Sustained Nano Systems have?
Sustained Nano Systems has a total of 40 patents globally. These patents belong to 4 unique patent families. Out of 40 patents, 30 patents are active.
How Many Patents did Sustained Nano Systems File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Sustained Nano Systems Applications Filed | Sustained Nano Systems Patents Granted |
| 2023 | – | 2 |
| 2022 | – | 1 |
| 2020 | 4 | 1 |
| 2019 | 1 | 2 |
| 2018 | 18 | 4 |
| 2017 | – | 2 |
| 2015 | 1 | 1 |
| 2013 | – | 1 |
| 2011 | – | 1 |
| 2010 | 4 | – |
How many Sustained Nano Systems patents are Alive/Dead?
Worldwide Patents
How Many Patents did Sustained Nano Systems File in Different Countries?
Countries in which Sustained Nano Systems Filed Patents
| Country | Patent |
| United States Of America | 7 |
| Japan | 4 |
| Canada | 4 |
| Europe | 4 |
| Australia | 3 |
| India | 3 |
| Mexico | 2 |
| Brazil | 2 |
| Israel | 2 |
| China | 2 |
| Austria | 1 |
| Germany | 1 |
| Italy | 1 |
Where are Research Centers of Sustained Nano Systems Patents Located?
Best Sustained Nano Systems Patents
US20090148498A1 is the most popular patent in the Sustained Nano Systems portfolio. It has received 27 citations so far from companies like Searete Llc, Dose Medical Corporation, Glaukos Corporation.
Below is the list of most cited patents of Sustained Nano Systems:
| Publication Number | Citation Count |
| US20090148498A1 | 27 |
| US20080292680A1 | 15 |
| US20100173000A1 | 9 |
| JP2012524779A | 3 |
| US10744099B2 | 2 |
| US10500163B2 | 1 |
| US10406102B2 | 1 |
| US8071119B2 | 1 |
What Percentage of Sustained Nano Systems US Patent Applications Were Granted?
Sustained Nano Systems (Excluding its subsidiaries) has filed 7 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 4 have been granted leading to a grant rate of 66.67%.
Below are the key stats of Sustained Nano Systems patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Sustained Nano Systems?
| Law Firm | Total Applications | Success Rate |
| Hedman & Costigan PC | 7 | 66.67% |
List of Sustained Nano Systems patents
| Sustained Nano Systems Patents | Title |
| US10744099B2 | Radiation Sterilization Of Hypercompresed Polymer Dosage Forms |
| US10500163B2 | Radiation Sterilization Of Hypercompressed Polymer Dosage Forms |
| US10406102B2 | Hypercompressed Pharmaceutical Formulations |
| US8071119B2 | Controlled Release Implantable Dispensing Device And Method |
| EP3651771B1 | Radiation Sterilization Of Hypercompressed Polymer Dosage Forms |
| EP2160184B1 | Hypercompressed Particles For Controlled Release Of Ophthalmic Medications |
| EP3651800A4 | Hypercompressed Pharmaceutical Formulations |
| CN111032054A | Radiation Sterilization Of Hypercompressed Polymer Dosage Forms |
| CN110913907A | Hypercompressed Pharmaceutical Formulations |
| DE602008054340T2 | Hypercompressed Particles For Controlled Release Of Ophthalmic Pharmaceuticals |
| IT201800016467T2 | Hypercompressed Particles For The Controlled Release Of Ophthalmic Drugs. |
| AU2008254989B2 | Hypercompressed Particles For Controlled Release Of Ophthalmic Medications |
| AU2018300080A1 | Hypercompressed Pharmaceutical Formulations |
| AU2018300071A1 | Radiation Sterilization Of Hypercompressed Polymer Dosage Forms |
| JP7357367B2 | Radiation Sterilization Of Ultracompacted Polymer Dosage Forms |
| JP6250005B2 | Controlled Release Formulation |
| JP2020531571A | Ultra-Compressed Pharmaceutical Formulation |
| CA2759807C | Controlled Release Dispensing Device |
| CA2704111C | Hypercompressed Particles For Controlled Release Of Ophthalmic Medications |
| IN266731B | Hypercompressed Particles For Controlled Release Of Ophthalmic Medications |
| IN202027003228A | Radiation Sterilization Of Hypercompressed Polymer Dosage Forms |
| IN202027003290A | Hypercompressed Pharmaceutical Formulations |
| CA3069159A1 | Hypercompressed Pharmaceutical Formulations |
| CA3069155A1 | Radiation Sterilization Of Hypercompressed Polymer Dosage Forms |
| IL271908A | Hypercompressed Pharmaceutical Formulations |
| IL271904A | Radiation Sterilization Of Hypercompressed Polymer Dosage Forms |
| BR112020000506A2 | Hypercompressed Pharmaceutical Formulations |
| BR112020000504A2 | Radiation Sterilization Of Hypercompressed Polymer Dosage Forms |
| MX397631B | Radiation Sterilization Of Hypercompressed Polymer Dose Forms. |
| MX2020000376A | Hypercompressed Pharmaceutical Formulations. |
| US20100173000A1 | Controlled Release Implantable Dispensing Device And Method |
| US20090148498A1 | Controlled Release Implantable Dispensing Device And Method |
| US20080292680A1 | Hypercompressed Polymer Particles For Controlled Release Ophthalmic Medications |
| EP2421517A4 | Controlled Release Dispensing Device |
| WO2019014280A1 | Hypercompressed Pharmaceutical Formulations |
| WO2019014269A1 | Radiation Sterilization Of Hypercompressed Polymer Dosage Forms |
| WO2010123563A3 | Controlled Release Dispensing Device |
| WO2008143906A3 | Hypercompressed Particles For Controlled Release Of Ophthalmic Medications |
| AT975790T | Hyperkomprimierte Teilchen Zur Kontrollierten Freisetzung Von Ophthalmischen Arzneimitteln |
| JP2012524779A | Controlled Release Dispensing Device |
What are Sustained Nano Systems key innovation segments?
What Technologies are Covered by Sustained Nano Systems?
The chart below distributes patents filed by Sustained Nano Systems